Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Heparin vs IV Heparin During VV ECMO for Respiratory Failure
NCT04496362Phase 4Active, not recruiting
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Oct 2018
- Primary completion
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin in respiratory failure, sponsored by Baylor Scott & White Research Institute. Started Oct 2018; status: active, not recruiting.
02
Drugs
heparin
03
Conditions
respiratory failure
Beyond the preview
Go deeper on NCT04496362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04496362.